Koyfin Home > Directory > Health Care > Acadia Pharmaceutica > EV / EBITDA (ntm)

Acadia Pharmaceutica EV / EBITDA (ntm) Chart (ACAD)

Acadia Pharmaceutica annual/quarterly EV / EBITDA (ntm) from 2020 to 2020. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the next twelve months (NTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
Other Valuation Metrics:
  • Acadia Pharmaceutica Market Cap for the quarter ending March 03, 2018 was $2,802m a -21.48% decrease of -602m year over year
  • Acadia Pharmaceutica Price / Book for the quarter ending March 03, 2018 was 8.34 a 10.81% increase of 0.90 year over year
  • Acadia Pharmaceutica Enterprise Value for the quarter ending March 03, 2018 was $2,461m a -19.25% decrease of -474m year over year
View Chart On Koyfin